Skip to Main Content
S. Karger AG
header search
Search
Advanced Search
Skip Nav Destination

Pathology and Neurotransmitter Abnormalities of Dementia with Lewy Bodies

Dement Geriatr Cogn Disord (2003) 17 (Suppl. 1): 3–14.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Latest advances in mechanisms of epileptic activity in Alzheimer’s disease and dementia with Lewy Bodies
  • Mariane Vicente
  • Kwaku Addo-Osafo
  • Keith Vossel
Frontiers in Neurology (2024) 15
Alzheimer’s Disease and Related Dementias: A Review of Evidence for Clinical Exercise Physiologists
  • Michael Bruneau
  • Branden Perry
Journal of Clinical Exercise Physiology (2024) 13 (1): 24.
Proprioceptive and olfactory deficits in individuals with Parkinson disease and mild cognitive impairment
  • Kuan-yi Li
  • Kristen A. Pickett
  • Hsuan-wei Fu
  • Rou-shayn Chen
Acta Neurologica Belgica (2024) 124 (2): 419.
Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies
  • John J. Alam
  • Paul Maruff
  • Susan R. Doctrow
  • Hui-May Chu
  • Jennifer Conway
  • Stephen N. Gomperts
  • Charlotte Teunissen
Neurology (2023) 101 (17)
La maladie à corps de Lewy : attention aux risques de complications iatrogènes
  • Lucie Pierrel
  • Anne Maheut-Bosser
  • Julien Gravoulet
  • François Dupuis
Le Pharmacien Clinicien (2023) 58 (4): 382.
Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
  • Ying Jiang
  • John J. Alam
  • Stephen N. Gomperts
  • Paul Maruff
  • Afina W. Lemstra
  • Ursula A. Germann
  • Philip H. Stavrides
  • Sandipkumar Darji
  • Sandeep Malampati
  • James Peddy
  • Cynthia Bleiwas
  • Monika Pawlik
  • Anna Pensalfini
  • Dun-Sheng Yang
  • Shivakumar Subbanna
  • Balapal S. Basavarajappa
  • John F. Smiley
  • Amanda Gardner
  • Kelly Blackburn
  • Hui-May Chu
  • Niels D. Prins
  • Charlotte E. Teunissen
  • John E. Harrison
  • Philip Scheltens
  • Ralph A. Nixon
Nature Communications (2022) 13 (1)
Association of β-Amyloid and Basal Forebrain With Cortical Thickness and Cognition in Alzheimer and Lewy Body Disease Spectra
  • Han Soo Yoo
  • Seun Jeon
  • Enrica Cavedo
  • MinJin Ko
  • Mijin Yun
  • Phil Hyu Lee
  • Young H. Sohn
  • Michel J. Grothe
  • Stefan Teipel
  • Harald Hampel
  • Alan C. Evans
  • Byoung Seok Ye
Neurology (2022) 98 (9)
Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer’s Disease in Clinical Practice
  • Matthieu Lilamand
  • Josué Clery
  • Agathe Vrillon
  • François Mouton-Liger
  • Emmanuel Cognat
  • Sinead Gaubert
  • Claire Hourregue
  • Matthieu Martinet
  • Julien Dumurgier
  • Jacques Hugon
  • Elodie Bouaziz-Amar
  • Claire Paquet
International Journal of Molecular Sciences (2022) 23 (21): 13488.
Cingulate Island Sign in Single Photon Emission Computed Tomography: Clinical Biomarker Correlations in Lewy Body Disease and Alzheimer’s Disease
  • Akinori Futamura
  • Sotaro Hieda
  • Yukiko Mori
  • Azusa Sugimoto
  • Hideyo Kasai
  • Takeshi Kuroda
  • Satoshi Yano
  • Kensaku Kasuga
  • Hidetomo Murakami
  • Takeshi Ikeuchi
  • Kenjiro Ono
  • Giulio Pasinetti
Journal of Alzheimer's Disease (2021) 79 (3): 1003.
Cholinergic Modulation of Glial Function During Aging and Chronic Neuroinflammation
  • Rashmi Gamage
  • Ingrid Wagnon
  • Ilaria Rossetti
  • Ryan Childs
  • Garry Niedermayer
  • Rose Chesworth
  • Erika Gyengesi
Frontiers in Cellular Neuroscience (2020) 14
Emerging regenerative medicine and tissue engineering strategies for Parkinson’s disease
  • James P. Harris
  • Justin C. Burrell
  • Laura A. Struzyna
  • H. Isaac Chen
  • Mijail D. Serruya
  • John A. Wolf
  • John E. Duda
  • D. Kacy Cullen
npj Parkinson's Disease (2020) 6 (1)
Engineered microtissue as an anatomically inspired model of Parkinson's disease
  • Elisia M. Clark
  • John C. O'Donnell
  • Laura A. Struzyna
  • H. Isaac Chen
  • John E. Duda
  • D. Kacy Cullen
Current Opinion in Biomedical Engineering (2020) 14: 75.
Gastrointestinal Transit Time in Parkinson’s Disease Using a Magnetic Tracking System
  • Karoline Knudsen
  • Anne-Mette Haase
  • Tatyana D. Fedorova
  • Anne Charlotte Bekker
  • Karen Østergaard
  • Klaus Krogh
  • Per Borghammer
Journal of Parkinson's Disease (2017) 7 (3): 471.
Synucleinopathies: common features and hippocampal manifestations
  • Weiwei Yang
  • Shun Yu
Cellular and Molecular Life Sciences (2017) 74 (8): 1485.
Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer’s Disease are Associated with Parkinsonism
  • Kolbørn Brønnick
  • Monica H. Breitve
  • Arvid Rongve
  • Dag Aarsland
Journal of Alzheimer's Disease (2016) 53 (4): 1277.
Review: Sporadic Parkinson's disease: development and distribution of α‐synuclein pathology
  • K. Del Tredici
  • H. Braak
Neuropathology and Applied Neurobiology (2016) 42 (1): 33.
Abnormal Echogenicity of the Substantia Nigra, Raphe Nuclei, and Third-Ventricle Width as Markers of Cognitive Impairment in Parkinsonian Disorders: A Cross-Sectional Study
  • Angela E. P. Bouwmans
  • Albert F. G. Leentjens
  • Werner H. Mess
  • Wim E. J. Weber
Parkinson's Disease (2016) 2016: 1.
Cerebrospinal Fluid Aβ42 Levels: When Physiological Become Pathological State
  • Alessandro Martorana
  • Francesco Di Lorenzo
  • Lorena Belli
  • Giuseppe Sancesario
  • Sofia Toniolo
  • Fabrizio Sallustio
  • Giulia Maria Sancesario
  • Giacomo Koch
CNS Neuroscience & Therapeutics (2015) 21 (12): 921.
Regional Multiple Pathology Scores Are Associated with Cognitive Decline in Lewy Body Dementias
  • David R. Howlett
  • David Whitfield
  • Mary Johnson
  • Johannes Attems
  • John T. O'Brien
  • Dag Aarsland
  • Mitchell K.P. Lai
  • Jasinda H. Lee
  • Christopher Chen
  • Clive Ballard
  • Tibor Hortobágyi
  • Paul T. Francis
Brain Pathology (2015) 25 (4): 401.
Regulation of dopamine D3 receptor in the striatal regions and substantia nigra in diffuse Lewy body disease
  • J. Sun
  • N.J. Cairns
  • J.S. Perlmutter
  • R.H. Mach
  • J. Xu
Neuroscience (2013) 248: 112.
Neuronal AChE splice variants and their non‐hydrolytic functions: redefining a target of AChE inhibitors?
  • M Zimmermann
British Journal of Pharmacology (2013) 170 (5): 953.
[123I]N‐ω‐fluoropropyl‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)nortropane single‐photon emission computed tomography brain imaging in the diagnosis of dementia with Lewy bodies
  • Zuzana Walker
  • Jeffrey L. Cummings
Alzheimer's & Dementia (2012) 8 (1): 74.
Agitation and Psychosis Associated With Dementia With Lewy Bodies Exacerbated by Modafinil Use
  • Eduardo Prado
  • Pongsatorn Paholpak
  • Myha Ngo
  • Verna Porter
  • Liana G. Apostolova
  • Rogério Marrocos
  • John M. Ringman
American Journal of Alzheimer's Disease & Other Dementias® (2012) 27 (7): 468.
Cognitive and structural magnetic resonance imaging features of Lewy body dementia and Alzheimer's disease
  • Miriam Jocelyn Rodriguez
  • Elizabeth Potter
  • Qian Shen
  • Warren Barker
  • Maria Greig‐Custo
  • Joscelyn Agron
  • David Loewenstein
  • Ranjan Duara
Alzheimer's & Dementia (2012) 8 (3): 211.
Patterns of gray matter atrophy in dementia with Lewy bodies: a voxel-based morphometry study
  • Rosie Watson
  • John T. O'Brien
  • Robert Barber
  • Andrew M. Blamire
International Psychogeriatrics (2012) 24 (4): 532.
Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases
  • Kelly Del Tredici
  • John E. Duda
Journal of the Neurological Sciences (2011) 310 (1-2): 100.
Olfactory system pathology as a model of Lewy neurodegenerative disease
  • John E. Duda
Journal of the Neurological Sciences (2010) 289 (1-2): 49.
Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction
  • Thomas G. Beach
  • Charles H. Adler
  • LihFen Lue
  • Lucia I. Sue
  • Jyothi Bachalakuri
  • Jonette Henry-Watson
  • Jeanne Sasse
  • Sarah Boyer
  • Scophil Shirohi
  • Reed Brooks
  • Jennifer Eschbacher
  • Charles L. White
  • Haru Akiyama
  • John Caviness
  • Holly A. Shill
  • Donald J. Connor
  • Marwan N. Sabbagh
  • Douglas G. Walker
Acta Neuropathologica (2009) 117 (6): 613.
A critical evaluation of current staging of α-synuclein pathology in Lewy body disorders
  • Kurt A. Jellinger
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2009) 1792 (7): 730.
Vroeg optredende symptomen van Dementie met Lewy Bodies: de waarde van de diagnose MCI-DLB en de mogelijke behandeling
  • M. Th. Feitsma
  • T. van Laar
  • P. L. J. Dautzenberg
Tijdschrift voor Gerontologie en Geriatrie (2009) 40 (4): 168.
Olfactory Dysfunction in Parkinson’s Disease
  • Sarah M. Kranick
  • John E. Duda
Neurosignals (2008) 16 (1): 35.
A critical reappraisal of current staging of Lewy-related pathology in human brain
  • Kurt A. Jellinger
Acta Neuropathologica (2008) 116 (1): 1.
Non‐hydrolytic functions of acetylcholinesterase
  • Susan A. Greenfield
  • Martina Zimmermann
  • Cherie E. Bond
The FEBS Journal (2008) 275 (4): 604.
Executive dysfunction and memory impairment in idiopathic REM sleep behavior disorder
  • J. Massicotte-Marquez
  • A. Décary
  • J-F Gagnon
  • M. Vendette
  • A. Mathieu
  • R. B. Postuma
  • J. Carrier
  • J. Montplaisir
Neurology (2008) 70 (15): 1250.
Cerebral amyloid angiopathy in Lewy body disease
  • K. A. Jellinger
  • J. Attems
Journal of Neural Transmission (2008) 115 (3): 473.
A not entirely benign procedure: progression of Parkinson’s disease
  • Kelly Del Tredici
  • Heiko Braak
Acta Neuropathologica (2008) 115 (4): 379.
Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance
  • Laura Parkkinen
  • Tuula Pirttilä
  • Irina Alafuzoff
Acta Neuropathologica (2008) 115 (4): 399.
Characterization of antibodies that selectively detect α-synuclein in pathological inclusions
  • Elisa A. Waxman
  • John E. Duda
  • Benoit I. Giasson
Acta Neuropathologica (2008) 116 (1): 37.
Cholinergic balance in dementia with Lewy bodies: reversible worsening of Parkinsonism at rivastigmine dosage modulation
  • F. Clerici
  • P. L. Ratti
  • S. Pomati
  • L. Maggiore
  • A. Elia
  • C. Mariani
Neurological Sciences (2007) 28 (5): 282.
EEG and clinical psychophysiological study of functional changes in the chronically ischemic brain upon an increase in cholinergic activity
  • N. D. Sorokina
  • G. V. Selitskii
  • N. S. Kositsyn
Human Physiology (2007) 33 (3): 285.
Cholinergic and other neurotransmitter mechanisms in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies
  • Paul T. Francis
  • Elaine K. Perry
Movement Disorders (2007) 22 (S17): S351.
Sonographic discrimination of dementia with Lewy bodies and Parkinson's disease with dementia
  • U. Walter
  • D. Dressler
  • A. Wolters
  • M. Wittstock
  • B. Greim
  • R. Benecke
Journal of Neurology (2006) 253 (4): 448.
Dementia with Lewy Bodies: Therapeutic Opportunities and Pitfalls
  • Anne-Lenora Henriksen
  • Clarke St. Dennis
  • Stephen M. Setter
  • John T. Tran
The Consultant Pharmacist (2006) 21 (7): 563.
Widespread and abundant α‐synuclein pathology in a neurologically unimpaired subject
  • Laura Parkkinen
  • Tuula Pirttilä
  • Markku Tervahauta
  • Irina Alafuzoff
Neuropathology (2005) 25 (4): 304.
The pathophysiology and treatment of dementia with Lewy bodies: An overview
  • Sue Woodward
British Journal of Neuroscience Nursing (2005) 1 (4): 164.
Are Parkinson’s Disease with dementia and Dementia with lewy Bodies the Same Entity?
  • Dag Aarsland
  • C. G. Ballard
  • Glenda Halliday
Journal of Geriatric Psychiatry and Neurology (2004) 17 (3): 137.
Role of Cholinesterase Inhibitors in Parkinson’s Disease and dementia with Lewy Bodies
  • Dag Aarsland
  • Urs P. Mosimann
  • Ian G. McKeith
Journal of Geriatric Psychiatry and Neurology (2004) 17 (3): 164.
  • Online ISSN 1421-9824
  • Print ISSN 1420-8008
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal